Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Viruses ; 13(9)2021 08 26.
Artículo en Inglés | MEDLINE | ID: mdl-34578270

RESUMEN

HIV-1 is a fast-evolving, genetically diverse virus presently classified into several groups and subtypes. The virus evolves rapidly because of an error-prone polymerase, high rates of recombination, and selection in response to the host immune system and clinical management of the infection. The rate of evolution is also influenced by the rate of virus spread in a population and nature of the outbreak, among other factors. HIV-1 evolution is thus driven by a range of complex genetic, social, and epidemiological factors that complicates disease management and prevention. Here, we quantify the evolutionary (substitution) rate heterogeneity among major HIV-1 subtypes and recombinants by analyzing the largest collection of HIV-1 genetic data spanning the widest possible geographical (100 countries) and temporal (1981-2019) spread. We show that HIV-1 substitution rates vary substantially, sometimes by several folds, both across the virus genome and between major subtypes and recombinants, but also within a subtype. Across subtypes, rates ranged 3.5-fold from 1.34 × 10-3 to 4.72 × 10-3 in env and 2.3-fold from 0.95 × 10-3 to 2.18 × 10-3 substitutions site-1 year-1 in pol. Within the subtype, 3-fold rate variation was observed in env in different human populations. It is possible that HIV-1 lineages in different parts of the world are operating under different selection pressures leading to substantial rate heterogeneity within and between subtypes. We further highlight how such rate heterogeneity can complicate HIV-1 phylodynamic studies, specifically, inferences on epidemiological linkage of transmission clusters based on genetic distance or phylogenetic data, and can mislead estimates about the timing of HIV-1 lineages.


Asunto(s)
Evolución Molecular , Variación Genética , VIH-1/clasificación , VIH-1/genética , Filogenia , Infecciones por VIH/virología , Humanos
2.
Artículo en Inglés | MEDLINE | ID: mdl-27103629

RESUMEN

The Ebola outbreak of 2013-15 infected more than 28 000 people and claimed more lives than all previous filovirus outbreaks combined. Governmental agencies, clinical teams, and the world scientific community pulled together in a multifaceted response ranging from prevention and disease control, to evaluating vaccines and therapeutics in human trials. As this epidemic is finally coming to a close, refocusing on long-term prevention strategies becomes paramount. Given the very real threat of future filovirus outbreaks, and the inherent uncertainty of the next outbreak virus and geographic location, it is prudent to consider the extent and implications of known natural diversity in advancing vaccines and therapeutic approaches. To facilitate such consideration, we have updated and enhanced the content of the filovirus portion of Los Alamos Hemorrhagic Fever Viruses Database. We have integrated and performed baseline analysis of all family ITALIC! Filoviridaesequences deposited into GenBank, with associated immune response data, and metadata, and we have added new computational tools with web-interfaces to assist users with analysis. Here, we (i) describe the main features of updated database, (ii) provide integrated views and some basic analyses summarizing evolutionary patterns as they relate to geo-temporal data captured in the database and (iii) highlight the most conserved regions in the proteome that may be useful for a T cell vaccine strategy.Database URL:www.hfv.lanl.gov.


Asunto(s)
Bases de Datos Genéticas , Infecciones por Filoviridae/virología , Filoviridae/genética , Filoviridae/inmunología , Infecciones por Filoviridae/inmunología , Humanos , Internet , New Mexico , Interfaz Usuario-Computador
3.
Nucleic Acids Res ; 40(Database issue): D587-92, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22064861

RESUMEN

Hemorrhagic fever viruses (HFVs) are a diverse set of over 80 viral species, found in 10 different genera comprising five different families: arena-, bunya-, flavi-, filo- and togaviridae. All these viruses are highly variable and evolve rapidly, making them elusive targets for the immune system and for vaccine and drug design. About 55,000 HFV sequences exist in the public domain today. A central website that provides annotated sequences and analysis tools will be helpful to HFV researchers worldwide. The HFV sequence database collects and stores sequence data and provides a user-friendly search interface and a large number of sequence analysis tools, following the model of the highly regarded and widely used Los Alamos HIV database [Kuiken, C., B. Korber, and R.W. Shafer, HIV sequence databases. AIDS Rev, 2003. 5: p. 52-61]. The database uses an algorithm that aligns each sequence to a species-wide reference sequence. The NCBI RefSeq database [Sayers et al. (2011) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res., 39, D38-D51.] is used for this; if a reference sequence is not available, a Blast search finds the best candidate. Using this method, sequences in each genus can be retrieved pre-aligned. The HFV website can be accessed via http://hfv.lanl.gov.


Asunto(s)
Bioterrorismo , Bases de Datos Genéticas , Virus/genética , Genes Virales , Genoma Viral , Anotación de Secuencia Molecular/normas , Control de Calidad , Alineación de Secuencia , Análisis de Secuencia
4.
BMC Bioinformatics ; 12: 51, 2011 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-21306634

RESUMEN

BACKGROUND: Large databases of genetic data are often biased in their representation. Thus, selection of genetic data with desired properties, such as evolutionary representation or shared genotypes, is problematic. Selection on the basis of epidemiological variables may not achieve the desired properties. Available automated approaches to the selection of influenza genetic data make a tradeoff between speed and simplicity on the one hand and control over quality and contents of the dataset on the other hand. A poorly chosen dataset may be detrimental to subsequent analyses. RESULTS: We developed a tool, Tree Pruner, for obtaining a dataset with desired evolutionary properties from a large, biased genetic database. Tree Pruner provides the user with an interactive phylogenetic tree as a means of editing the initial dataset from which the tree was inferred. The tree visualization changes dynamically, using colors and shading, reflecting Tree Pruner actions. At the end of a Tree Pruner session, the editing actions are implemented in the dataset. Currently, Tree Pruner is implemented on the Influenza Research Database (IRD). The data management capabilities of the IRD allow the user to store a pruned dataset for additional pruning or for subsequent analysis. Tree Pruner can be easily adapted for use with other organisms. CONCLUSIONS: Tree Pruner is an efficient, manual tool for selecting a high-quality dataset with desired evolutionary properties from a biased database of genetic sequences. It offers an important alternative to automated approaches to the same goal, by providing the user with a dynamic, visual guide to the ongoing selection process and ultimate control over the contents (and therefore quality) of the dataset.


Asunto(s)
Minería de Datos/métodos , Sistemas de Administración de Bases de Datos , Bases de Datos Genéticas , Programas Informáticos , Biología Computacional/métodos , Filogenia , Sesgo de Selección
5.
J Bacteriol ; 189(9): 3680-1, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17337577

RESUMEN

Bacillus thuringiensis is an insect pathogen that is widely used as a biopesticide (E. Schnepf, N. Crickmore, J. Van Rie, D. Lereclus, J. Baum, J. Feitelson, D. R. Zeigler, and D. H. Dean, Microbiol. Mol. Biol. Rev. 62:775-806, 1998). Here we report the finished, annotated genome sequence of B. thuringiensis Al Hakam, which was collected in Iraq by the United Nations Special Commission (L. Radnedge, P. Agron, K. Hill, P. Jackson, L. Ticknor, P. Keim, and G. Andersen, Appl. Environ. Microbiol. 69:2755-2764, 2003).


Asunto(s)
Bacillus thuringiensis/genética , Genoma Bacteriano , Secuencia de Bases , Datos de Secuencia Molecular , Análisis de Secuencia de ADN
6.
J Bacteriol ; 188(9): 3382-90, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16621833

RESUMEN

Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis are closely related gram-positive, spore-forming bacteria of the B. cereus sensu lato group. While independently derived strains of B. anthracis reveal conspicuous sequence homogeneity, environmental isolates of B. cereus and B. thuringiensis exhibit extensive genetic diversity. Here we report the sequencing and comparative analysis of the genomes of two members of the B. cereus group, B. thuringiensis 97-27 subsp. konkukian serotype H34, isolated from a necrotic human wound, and B. cereus E33L, which was isolated from a swab of a zebra carcass in Namibia. These two strains, when analyzed by amplified fragment length polymorphism within a collection of over 300 of B. cereus, B. thuringiensis, and B. anthracis isolates, appear closely related to B. anthracis. The B. cereus E33L isolate appears to be the nearest relative to B. anthracis identified thus far. Whole-genome sequencing of B. thuringiensis 97-27and B. cereus E33L was undertaken to identify shared and unique genes among these isolates in comparison to the genomes of pathogenic strains B. anthracis Ames and B. cereus G9241 and nonpathogenic strains B. cereus ATCC 10987 and B. cereus ATCC 14579. Comparison of these genomes revealed differences in terms of virulence, metabolic competence, structural components, and regulatory mechanisms.


Asunto(s)
Bacillus anthracis/genética , Bacillus cereus/genética , Bacillus thuringiensis/genética , Genoma Bacteriano , Análisis de Secuencia , Aminoácidos/metabolismo , Animales , Bacillus cereus/patogenicidad , Bacillus cereus/fisiología , Cápsulas Bacterianas/biosíntesis , Cápsulas Bacterianas/genética , Metabolismo de los Hidratos de Carbono , Evolución Molecular , Humanos , Esporas Bacterianas/crecimiento & desarrollo , Virulencia/genética
7.
J Neuroimmunol ; 155(1-2): 1-12, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15342191

RESUMEN

Neuropeptide Y (NPY) increases survival in experimental septic shock, which might be mediated by cardiovascular and/or immunological effects. To study the latter hypothesis, we monitored blood leukocyte subsets over 96 h after intravenous (i.v.) application of LPS in chronically i.v.-cannulated rats. LPS induced a dramatic leukopenia at 4 h after challenge, which was blunted in NPY-treated animals by stabilizing granulocyte and T-lymphocyte numbers. In addition, NPY treatment prevented tissue immigration of monocytes at early time points and consecutively mobilized activated monocytes from the third day after challenge. RT-PCR and in vitro adhesion studies provided evidence for a NPY Y2 receptor-mediated effect on monocytes. Thus, NPY treatment has profound receptor-specific effects on the migration and adhesion of leukocytes under endotoxemic conditions.


Asunto(s)
Quimiotaxis de Leucocito/efectos de los fármacos , Endotoxemia/tratamiento farmacológico , Monocitos/efectos de los fármacos , Neuropéptido Y/farmacología , Receptores de Neuropéptido Y/metabolismo , Animales , Apoptosis/efectos de los fármacos , Apoptosis/inmunología , Adhesión Celular/efectos de los fármacos , Adhesión Celular/genética , Células Cultivadas , Quimiotaxis de Leucocito/inmunología , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/inmunología , Endotoxemia/inducido químicamente , Endotoxemia/fisiopatología , Citometría de Flujo , Radicales Libres/metabolismo , Inyecciones Intravenosas , Leucopenia/inducido químicamente , Leucopenia/fisiopatología , Lipopolisacáridos , Masculino , Monocitos/patología , Monocitos/fisiología , Neuropéptido Y/metabolismo , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas Lew , Receptores de Neuropéptido Y/genética , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T/patología , Factor de Necrosis Tumoral alfa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA